The research of Dr. Rushika Perera’s laboratory in the Center for Vector-Borne Infectious Diseases (CVID), is focused on understanding the impact of cellular metabolism on the replication of mosquito- and tick-borne flaviviruses within their vertebrate hosts and Arthropod vectors. Specifically, we use a systems biology approach including metabolomics and proteomics combined with molecular virology, cell biology, biochemistry and structural biology to study flavivirus-host interactions. Similar to other positive strand RNA viruses, flaviviruses cause significant perturbations to the host metabolome to facilitate the formation of replication factories within specialized membrane structures. These structures are required for viral genome replication, assembly and egress. The host metabolome also fulfills the energy requirements for virus replication. Therefore, it is a key avenue to understand the dynamics of virus-host interactions and provides a novel avenue to identify targets for antiviral intervention. The goal of her research is to identify control points in cellular metabolic pathways that are required for virus replication, and evaluate these control points as novel targets for antiviral intervention.
The Perera Lab supports ‘Diversity’, practices ‘Equity & Inclusion’, ensures ‘Social Justice’.
The Perera Lab abides by Colorado State University’s Principles of Community.
COVID-19: Developing platforms to test antivirals against SARS-CoV-2
The Perera lab (in collaboration with the Geiss Laboratory and the CSU OVPR) has mobilized testing of FDA-approved antiviral drugs that can be repurposed and rapidly driven into clinical trials, as well as new compounds that can be evaluated for efficacy against SARS-CoV-2. We are currently working with collaborators and partners from around the world to screen their drug and compound inventories.view project
Metabolite biomarkers of severe disease, resolution and therapeutic efficacy
We utilize Systems Biology based-metabolomics to develop small molecule biosignatures of severe disease. These biosignatures can be utilized for early detection and triaging of patients, to better assist clinical management of those at greater risk. They are also powerful indicators of disease resolution, recurrence and/or therapeutic efficacy.view project
Metabolic basis of mosquito-endosymbiont-virus interactions
These studies will identify biochemical pathways that change in the mosquito following infection with arboviruses, and how the endosymbiont Wolbachia used to control virus transmission in Aedes aegypti may be metabolically competing with the virus. Identifying these pathways that are integral to mosquito biology, provide a novel avenue to interfere with vector transmission of the virus.view project
Exploiting Vulnerabilities in Mosquito Metabolism for Prevention of Human Arboviral Transmissions
Zika, dengue, chikungunya and yellow fever viruses are spread by the same mosquito vector, Aedes aegypti. The Perera lab studies specific metabolic processes in mosquitos required for successful viral replication. These studies will identify metabolic “choke-points” that can be exploited to develop interventions and thus block mosquito-human viral transmission.view project
Metabolic basis of insecticide resistance
We are investigating the metabolic basis of insecticide resistance in Aedes aegypti. We have developed capability to trace the metabolites of insecticides and measure the enzymatic activities responsible for insecticide break down and development of resistance. These studies will assist in driving improvements in insecticide design and informed use of insecticides.view project
RNase L activation in the cytoplasm induces aberrant processing of mRNAs in the nucleus.
Burke JM, Ripin N, Ferretti MB, St Clair LA, Worden-Sapper ER, Salgado F, Sawyer SL, Perera R, Lynch KW, Parker R.
PLoS Pathog. 2022 Nov 1;18(11):e1010930. doi: 10.1371/journal.ppat.1010930. eCollection 2022 Nov. PMID: 36318584
Expression of fatty acid synthase genes and their role in development and arboviral infection of Aedes aegypti.
Chotiwan N, Brito-Sierra CA, Ramirez G, Lian E, Grabowski JM, Graham B, Hill CA, Perera R.
Parasit Vectors. 2022 Jun 27;15(1):233. doi: 10.1186/s13071-022-05336-1. PMID: 35761349
Acyl-Coa Thioesterases: A Rheostat That Controls Activated Fatty Acids Modulates Dengue Virus Serotype 2 Replication.
St Clair LA, Mills SA, Lian E, Soma PS, Nag A, Montgomery C, Ramirez G, Chotiwan N, Gullberg RC, Perera R.
Viruses. 2022 Jan 25;14(2):240. doi: 10.3390/v14020240. PMID: 35215835
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies.
Terry JS, Anderson LB, Scherman MS, McAlister CE, Perera R, Schountz T, Geiss BJ.
bioRxiv. 2020 Sep 3:2020.09.03.280370. doi: 10.1101/2020.09.03.280370. Preprint.
Increased serum sialic acid is associated with morbidity and mortality in a murine model of dengue disease.
Espinosa DA, Beatty PR, Puerta-Guardo H, Islam MN, Belisle JT, Perera R, Harris E.
J Gen Virol. 2019 Sep 17. doi: 10.1099/jgv.0.001319. [Epub ahead of print]
Lab Principal Investigator (PI)
Director, Antiviral Testing Laboratory
Co-Director, Center for Metabolism of Infectious Diseases (C4MInD.org)
Research Scientist I
Graduate Research Assistant
Graduate Research Assistant
Undergraduate Student Researcher
news and updates view all
PhD Student Gaby Ramirez received the 2022-23 Advancing Education Scholarship in recognition of outstanding achievement in promoting equities for underrepresented populations.
Top Colorado State University researchers mobilized their disciplines over the course of the past year to address challenges raised by the global coronavirus pandemic.
On International Women’s Day, we celebrate the contributions and impact from women everywhere, including all of the CSU scientists and researchers who have led in the fight against COVID-19
Lab: Center for Vector-Borne Infectious Diseases room 130
Office: Center for Vector-Borne Infectious Diseases room 172